TriAltus Bioscience
Bob Shufflebarger has extensive work experience, beginning with their role as Marketing Manager at Southern Research from 1995 to 1998. Bob then worked at AmSouth Bank as a Market Research Manager from 1998 to 2000. From 2000 to 2017, they worked at Atherotech Inc., where they held the roles of Chief Operating Officer, Vice President Operations, and Director of Operations. In 2017, they founded and became the CEO of TriAltus Bioscience.
Bob Shufflebarger received their MBA from Duke University between 1993 and 1995. Bob also obtained a BS in Chemistry from Birmingham-Southern College between 1982 and 1986.
This person is not in any teams
TriAltus Bioscience
TriAltus develops innovative tools for the production and purification of genetically-engineered proteins. Their novel affinity tag system delivers proteins with ultra-high purity and yield in a single step. Having proven the CLīM technology on some extremely difficult proteins, TriAltus is now developing R&D partnerships to use CLīM to purify proteins for customer-defined projects.